Kodiak Sciences Inc. ( KOD) - Key Metrics
KOD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.05 | -$0.74 | -$0.74 |
| 2026Q1 | $0 | -$0.94 | -$0.65 | -$0.66 |
| 2025Q4 | $0 | -$1.07 | -$0.74 | -$0.74 |
| 2025Q3 | $0 | -$1.16 | -$0.62 | -$0.62 |
| 2025Q2 | $0 | -$1.03 | -$0.66 | -$0.66 |
KOD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.28 |
| 2026Q1 | 0% | -10.14 |
| 2025Q4 | 0% | -6.72 |
| 2025Q3 | 0% | -3.53 |
| 2025Q2 | 0% | -0.91 |
KOD
Price: $81.02
52 week price:
Earnings Per Share: -4.19 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 76500
Market Capitalization: 5.9 billion